Subspecialties

Patients with myopia often get poorer results from accommodating IOLs than those without – and a recent study explains why

For retina stem cell researchers, growing and purifying lots of RGCs from hPSCs has been hard… until now

Marine mammals have tear films filled with interesting antimicrobial agents – and understanding the compounds present might one day lead to new antibiotic drugs

A retrospective study by the Neuromyelitis Optica Study Group helps physicians better understand the challenging disease

Photoreceptors – and the retina in general – are highly metabolically active. But their maxed-out mitochondria can’t give much more. And when even small metabolic imbalances arise…

Three new pipeline therapies may offer relief to patients with ocular surface disease

Daniel Black discusses his experience with the ZEISS Cataract Suite markerless in the latest episode of In Conversation With…

The unveiling of SPECTRALIS® OCT angiography* is one of the highlights for Heidelberg Engineering in 2016. Its Managing Director Dr. Kester Nahen explains the distinctive features and new possibilities of this technology.

5-year ATOM2 trial data confirms that 0.01% atropine is more effective at slowing myopia progression than 0.1% and 0.5% doses

A specialized imaging technique has revealed two previously unknown structures of the cornea